A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions

Obesity

Interventions

DRUG

Tradipitant

Oral capsule

DRUG

Placebo

Oral capsule

Trial Locations (3)

RECRUITING

Vanda Investigational Site, New York

RECRUITING

Vanda Investigational Site, Rochester

RECRUITING

Vanda Investigational Site, Los Angeles